XML 32 R62.htm IDEA: XBRL DOCUMENT v2.4.1.9
Commitments and Contingencies (Actions In Which We Are The Defendant) (Detail)
In Millions, unless otherwise specified
3 Months Ended 0 Months Ended 12 Months Ended 24 Months Ended 3 Months Ended 1 Months Ended 1 Months Ended
Mar. 30, 2014
Effexor [Member]
USD ($)
Mar. 30, 2014
Neurontin [Member]
USD ($)
Jun. 30, 2014
Patent Infringement [Member]
Effexor [Member]
Teva Canada Limited Versus Pfizer Canada Inc. [Member]
Pending Litigation [Member]
CAD
Dec. 31, 2006
Patent Infringement [Member]
Effexor [Member]
Teva Canada Limited Versus Pfizer Canada Inc. [Member]
Pending Litigation [Member]
Patents
Dec. 31, 2012
Patent Infringement [Member]
Effexor [Member]
Teva Canada Limited Versus Pfizer Canada Inc. [Member]
Pending Litigation [Member]
CAD
Mar. 29, 2015
Damages from Product Defects [Member]
Class Action Versus American Optical Corporation And Various Other Defendants [Member]
Pending Litigation [Member]
Claim
Mar. 29, 2015
Damages from Product Defects [Member]
Reglan [Member]
court
state
Jan. 31, 2015
Violation Of Securities Law, Failure to Disclose Material Information [Member]
U.S. District Court For The Southern District Of New York Versus Pfizer And Several Of Our Current And Former Officers [Member]
Settled Litigation [Member]
USD ($)
Apr. 30, 2014
Sales And Marketing Inconsistent with Patent [Member]
Neurontin [Member]
Class Action Versus Pfizer Inc. [Member]
Settled Litigation [Member]
USD ($)
Mar. 29, 2015
Average Wholesale Price [Member]
State Governments Versus Pfizer, Pfizer Subsidiaries and Other Pharmaceutical Manufacturers [Member]
Pending Litigation [Member]
Actions
Mar. 31, 2013
Environmental Remediation Litigation [Member]
lagoon
Dec. 31, 2009
Product Pricing [Member]
Protonix / Pantoprazole [Member]
U.S. Department of Justice Versus Pfizer [Member]
Actions
Loss Contingencies [Line Items]                        
Number of patents       1us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
/ us-gaap_LitigationCaseAxis
= pfe_TevaCanadaLimitedVersusPfizerCanadaInc.Member
/ us-gaap_LitigationStatusAxis
= us-gaap_PendingLitigationMember
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= pfe_PatentInfringementMember
/ us-gaap_ProductOrServiceAxis
= pfe_EffexorMember
               
Litigation settlement, expense $ 50.0us-gaap_GainLossRelatedToLitigationSettlement
/ us-gaap_ProductOrServiceAxis
= pfe_EffexorMember
$ 620.0us-gaap_GainLossRelatedToLitigationSettlement
/ us-gaap_ProductOrServiceAxis
= pfe_NeurontinMember
    52.5us-gaap_GainLossRelatedToLitigationSettlement
/ us-gaap_LitigationCaseAxis
= pfe_TevaCanadaLimitedVersusPfizerCanadaInc.Member
/ us-gaap_LitigationStatusAxis
= us-gaap_PendingLitigationMember
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= pfe_PatentInfringementMember
/ us-gaap_ProductOrServiceAxis
= pfe_EffexorMember
    $ 400.0us-gaap_GainLossRelatedToLitigationSettlement
/ us-gaap_LitigationCaseAxis
= pfe_U.S.DistrictCourtForTheSouthernDistrictOfNewYorkVersusPfizerAndSeveralOfOurCurrentAndFormerOfficersMember
/ us-gaap_LitigationStatusAxis
= us-gaap_SettledLitigationMember
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= pfe_ViolationOfSecuritiesLawFailuretoDiscloseMaterialInformationMember
       
Loss contingency, damages awarded, value     125us-gaap_LossContingencyDamagesAwardedValue
/ us-gaap_LitigationCaseAxis
= pfe_TevaCanadaLimitedVersusPfizerCanadaInc.Member
/ us-gaap_LitigationStatusAxis
= us-gaap_PendingLitigationMember
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= pfe_PatentInfringementMember
/ us-gaap_ProductOrServiceAxis
= pfe_EffexorMember
                 
Loss contingency, pending claims, number           59,000us-gaap_LossContingencyPendingClaimsNumber
/ us-gaap_LitigationCaseAxis
= pfe_ClassActionVersusAmericanOpticalCorporationAndVariousOtherDefendantsMember
/ us-gaap_LitigationStatusAxis
= us-gaap_PendingLitigationMember
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= us-gaap_DamagesFromProductDefectsMember
           
Litigation settlement, amount                 $ 325us-gaap_LitigationSettlementAmount
/ us-gaap_LitigationCaseAxis
= pfe_ClassActionVersusPfizerInc.Member
/ us-gaap_LitigationStatusAxis
= us-gaap_SettledLitigationMember
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= pfe_SalesAndMarketingInconsistentwithPatentMember
/ us-gaap_ProductOrServiceAxis
= pfe_NeurontinMember
     
Number of federal and state courts which have rejected theory of liability (more than)             100pfe_NumberOfFederalAndStateCourtsWhichHaveRejectedTheoryofLiability
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= us-gaap_DamagesFromProductDefectsMember
/ us-gaap_ProductOrServiceAxis
= pfe_ReglanMember
         
Number of states which are applying the theory of liability             30pfe_NumberofStatesWhichAreApplyingTheTheoryofLiability
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= us-gaap_DamagesFromProductDefectsMember
/ us-gaap_ProductOrServiceAxis
= pfe_ReglanMember
         
Number of actions                   2pfe_NumberOfActions
/ us-gaap_LitigationCaseAxis
= pfe_StateGovernmentsVersusPfizerPfizerSubsidiariesandOtherPharmaceuticalManufacturersMember
/ us-gaap_LitigationStatusAxis
= us-gaap_PendingLitigationMember
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= pfe_AverageWholesalePriceMember
  2pfe_NumberOfActions
/ us-gaap_LitigationCaseAxis
= pfe_U.S.DepartmentofJusticeVersusPfizerMember
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= pfe_ProductPricingMember
/ us-gaap_ProductOrServiceAxis
= pfe_ProtonixPantoprazoleMember
Feasibility Study, Number Of Lagoons                     2pfe_FeasibilityStudyNumberOfLagoons
/ us-gaap_LossContingenciesByNatureOfContingencyAxis
= pfe_EnvironmentalRemediationLitigationMember